Daytime Sleepiness in Patients Diagnosed with Sarcoidosis Compared with the General Population
Background. The aim of this study was to analyze daytime sleepiness in a sample of patients diagnosed with sarcoidosis. Methods. A sample of 1197 German sarcoidosis patients was examined with the Epworth Sleepiness Scale (ESS), the Fatigue Assessment Scale, the Hospital Anxiety and Depression Scale,...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2018/6853948 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832555531620843520 |
|---|---|
| author | Andreas Hinz Kristina Geue Markus Zenger Hubert Wirtz Andrea Bosse-Henck |
| author_facet | Andreas Hinz Kristina Geue Markus Zenger Hubert Wirtz Andrea Bosse-Henck |
| author_sort | Andreas Hinz |
| collection | DOAJ |
| description | Background. The aim of this study was to analyze daytime sleepiness in a sample of patients diagnosed with sarcoidosis. Methods. A sample of 1197 German sarcoidosis patients was examined with the Epworth Sleepiness Scale (ESS), the Fatigue Assessment Scale, the Hospital Anxiety and Depression Scale, the Pittsburgh Sleep Quality Index, and the Short-Form Health Survey (SF-8). The patients’ ESS mean scores were compared with those obtained from a large general population sample. Results. Exactly 50% of the patients reached the criterion (ESS > 10) for excessive daytime sleepiness, compared with only 22.1% in the general population. The effect size for the mean score difference between both samples was d=0.62. The number of affected organs and the number of concomitant diseases proved to be significant independent predictors of daytime sleepiness. Sleepiness was associated with fatigue (r=0.45), anxiety (r=0.23), depression (r=0.28), sleep problems (r=0.23), and detriments in physical (r=−0.29) and mental (r=−0.28) quality of life. Conclusions. The issue of excessive daytime sleepiness should be considered in the management of sarcoidosis. |
| format | Article |
| id | doaj-art-512897baaf5f4d998edb1709ec1c973b |
| institution | Kabale University |
| issn | 1198-2241 1916-7245 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Respiratory Journal |
| spelling | doaj-art-512897baaf5f4d998edb1709ec1c973b2025-02-03T05:47:53ZengWileyCanadian Respiratory Journal1198-22411916-72452018-01-01201810.1155/2018/68539486853948Daytime Sleepiness in Patients Diagnosed with Sarcoidosis Compared with the General PopulationAndreas Hinz0Kristina Geue1Markus Zenger2Hubert Wirtz3Andrea Bosse-Henck4Department of Medical Psychology and Medical Sociology, University of Leipzig, Leipzig, GermanyDepartment of Medical Psychology and Medical Sociology, University of Leipzig, Leipzig, GermanyFaculty of Applied Human Studies, University of Applied Sciences Magdeburg and Stendal, Stendal, GermanyDepartment of Respiratory Medicine, University of Leipzig, Leipzig, GermanyDepartment of Respiratory Medicine, University of Leipzig, Leipzig, GermanyBackground. The aim of this study was to analyze daytime sleepiness in a sample of patients diagnosed with sarcoidosis. Methods. A sample of 1197 German sarcoidosis patients was examined with the Epworth Sleepiness Scale (ESS), the Fatigue Assessment Scale, the Hospital Anxiety and Depression Scale, the Pittsburgh Sleep Quality Index, and the Short-Form Health Survey (SF-8). The patients’ ESS mean scores were compared with those obtained from a large general population sample. Results. Exactly 50% of the patients reached the criterion (ESS > 10) for excessive daytime sleepiness, compared with only 22.1% in the general population. The effect size for the mean score difference between both samples was d=0.62. The number of affected organs and the number of concomitant diseases proved to be significant independent predictors of daytime sleepiness. Sleepiness was associated with fatigue (r=0.45), anxiety (r=0.23), depression (r=0.28), sleep problems (r=0.23), and detriments in physical (r=−0.29) and mental (r=−0.28) quality of life. Conclusions. The issue of excessive daytime sleepiness should be considered in the management of sarcoidosis.http://dx.doi.org/10.1155/2018/6853948 |
| spellingShingle | Andreas Hinz Kristina Geue Markus Zenger Hubert Wirtz Andrea Bosse-Henck Daytime Sleepiness in Patients Diagnosed with Sarcoidosis Compared with the General Population Canadian Respiratory Journal |
| title | Daytime Sleepiness in Patients Diagnosed with Sarcoidosis Compared with the General Population |
| title_full | Daytime Sleepiness in Patients Diagnosed with Sarcoidosis Compared with the General Population |
| title_fullStr | Daytime Sleepiness in Patients Diagnosed with Sarcoidosis Compared with the General Population |
| title_full_unstemmed | Daytime Sleepiness in Patients Diagnosed with Sarcoidosis Compared with the General Population |
| title_short | Daytime Sleepiness in Patients Diagnosed with Sarcoidosis Compared with the General Population |
| title_sort | daytime sleepiness in patients diagnosed with sarcoidosis compared with the general population |
| url | http://dx.doi.org/10.1155/2018/6853948 |
| work_keys_str_mv | AT andreashinz daytimesleepinessinpatientsdiagnosedwithsarcoidosiscomparedwiththegeneralpopulation AT kristinageue daytimesleepinessinpatientsdiagnosedwithsarcoidosiscomparedwiththegeneralpopulation AT markuszenger daytimesleepinessinpatientsdiagnosedwithsarcoidosiscomparedwiththegeneralpopulation AT hubertwirtz daytimesleepinessinpatientsdiagnosedwithsarcoidosiscomparedwiththegeneralpopulation AT andreabossehenck daytimesleepinessinpatientsdiagnosedwithsarcoidosiscomparedwiththegeneralpopulation |